Most Recent
SkyCity shareholder can’t bring action over $67M AUSTRAC penalty
A SkyCity shareholder has lost his bid to bring a case against former executives and directors at the ASX-listed casino seeking to recoup a $67 million penalty over breaches of money laundering regulations. 
Fortescue, Element Zero reach settlement in trade secrets case
After losing a fight over access to millions of seized documents, Fortescue has settled its trade secrets case against green iron company Element Zero.
Construction PRO
APAC shareholders must hand over silk, G+T advice in fight with Dexus
Real estate asset manager Dexus has won access to advice given by the lawyers of two shareholders of airport operator APAC over an alleged breach of a shareholder deed. 
Construction PRO
Court throws out native title appeal over AngloGold mining leases
An appeals court has confirmed that mining companies AngloGold and IGO Limited did not need to renegotiate native title approvals when they consolidated 31 existing mining leases into a single lease. 
Light & Wonder employees can’t dodge subpoenas in Aristocrat case
A judge has signed off on subpoenas compelling employees of gaming company Light & Wonder to give evidence in a US case by Aristocrat alleging misuse of confidential information about its popular Dragon Link poker machine.
Takeovers Panel says Cosette can’t shutter Mayne’s Adelaide drug plant
The Takeovers Panel has found Cosette cannot close a Mayne Pharma drug manufacturing plant in Adelaide, another win for Mayne in its push to block the US drug maker from walking away from their $672 million merger.
Mayne wins extension of FIRB deadline for Cosette takeover
The Foreign Investment Review Board has extended the deadline for ruling on Cosette's proposed $672 million takeover of Mayne Pharma.
Mayne, Cosette row to be decided on merits after panel resets merger clock
The Takeovers Panel has agreed to hear Mayne Pharma's latest dispute with Cosette over the US drug maker's attempts to walk away from their $672 million merger agreement and extended the timeline for completing the deal.
Mayne wins breathing room in fight to get Cosette merger over the line
Mayne Pharma has secured an extension of the deadline for securing Foreign Investment Review Board approval of its $672 million tie-up with US drug maker Cosette.
Judge rejects ratchet contingency fee in MinRes class action
A judge has ordered a flat contingency fee at a rate below the maximum sought by the firm running a class action against Mineral Resources, agreeing with a colleague that recent shareholder class action losses don't justify a higher percentage.